Sign in
8-K

Current Report

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001104659-20-109500

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading tm2031923d1_8k.htm…